Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2022-07-18 Board/Management Inform…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It explicitly lists the former CEO, the new CEO, the reason for the change, and the effective date. This falls directly under the definition of Board/Management Information (MANG).
2022-07-18 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of Board/Management Information, which covers changes in the company's board of directors.
2022-07-18 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Aprogen MED. It details specific changes in share ownership for major shareholders and related parties due to a merger. This type of filing is a regulatory requirement for disclosing significant changes in ownership structure, which falls under the 'Major Shareholding Notification' category.
2022-07-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a mandatory regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership, including major shareholders and special related parties, and specifies the purpose of holding (management influence). This fits the definition of a Major Shareholding Notification.
2022-07-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholding notifications and changes in special relationships. This falls under the 'Major Shareholding Notification' category.
2022-07-12 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Aprogen Medicines. It specifically details a 'Correction Report' (정정신고) for a previously filed report, updating key terms such as maturity dates, interest payment methods, and payment schedules. This falls under the category of capital and financing updates, as it relates to the issuance and modification of debt instruments.
2022-07-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.